Thank you for requesting a meeting at
TCT 2022!
One of our experts will be in touch with you shortly.
Since inception in 1992, Medpace has conducted hundreds of Phase I-IV cardiovascular trials for drugs and medical devices. With the Medpace Different, sponsors benefit from our in-house board-certified cardiologists with strong backgrounds in academic clinical practice and pharmaceutical development, operational and regulatory teams with significant global experience, and an ECG Core Laboratory, who provides sponsors with the most reliable, consistent and timely electrocardiographic services. Interested in Medpace’s extensive experience in Rare Diseases?
